Korro Bio (KRRO) Total Non-Current Liabilities (2021 - 2025)
Historic Total Non-Current Liabilities for Korro Bio (KRRO) over the last 5 years, with Q3 2025 value amounting to $61.0 million.
- Korro Bio's Total Non-Current Liabilities fell 349.4% to $61.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.0 million, marking a year-over-year decrease of 349.4%. This contributed to the annual value of $64.4 million for FY2024, which is 2693.15% up from last year.
- Per Korro Bio's latest filing, its Total Non-Current Liabilities stood at $61.0 million for Q3 2025, which was down 349.4% from $63.9 million recorded in Q2 2025.
- In the past 5 years, Korro Bio's Total Non-Current Liabilities registered a high of $64.4 million during Q4 2024, and its lowest value of $8.9 million during Q4 2022.
- In the last 5 years, Korro Bio's Total Non-Current Liabilities had a median value of $53.8 million in 2021 and averaged $49.1 million.
- Per our database at Business Quant, Korro Bio's Total Non-Current Liabilities crashed by 8363.55% in 2022 and then soared by 55744.9% in 2024.
- Quarter analysis of 5 years shows Korro Bio's Total Non-Current Liabilities stood at $54.4 million in 2021, then plummeted by 83.64% to $8.9 million in 2022, then skyrocketed by 469.01% to $50.7 million in 2023, then rose by 26.93% to $64.4 million in 2024, then decreased by 5.23% to $61.0 million in 2025.
- Its Total Non-Current Liabilities was $61.0 million in Q3 2025, compared to $63.9 million in Q2 2025 and $61.8 million in Q1 2025.